Silicon level in skin tissues of normal female individuals
DOI:
https://doi.org/10.66344/jpad.v28i2.1101Keywords:
Silicon, skin, topical, accumulationAbstract
Objective To evaluate silicon level in normal skin tissue.
Methods The silicon levels in skin samples were measured using an atomic absorbance spectrophotometer in 37 healthy normal females who had never received silicone injection and compared with those who had developed granuloma after silicone injection..
Results Low silicon level (44.07±75.86 µg/g) was found in skin tissues of normal individuals as compared to those who developed post-silicone granuloma (1709.21±1851.72 µg/g).
Conclusion Silicon may be found in normal skin tissue due to daily use of cosmetic products; however the level is significantly low.
References
1. Price CT, Koval KJ, Langford JR. Silicon: A review of its potential role in the prevention and treatment of postmenopausal osteoporosis. Int J Endocrinol. 2013; Article ID 316783:1-7.
2. Chasan PE. The history of injectable silicon fluids for soft-tissue augmentation. Plast Reconstr Surg. 2007;120:2034-40.
3. Eighteenth Report of the Joint FAO/WHO Expert Committee on Food Additives, Wld Hlth Org. techn. Rep. Ser., 1974, No. 557. FAO Nutrition Meetings Report Series,1974,No.54.http://www.inchem.org/documents/jecfa/jecmono/v06je42.htm
4. Teuber S, Yoshida S, Gershwin E. Immunopathologic effects of silicone breast implants. West J Med. 1995;162:418-25.
5. Narins RS, Beer K. Liquid injectable silicon: A review of its history, immunology, technical, consideration, complication, and potential. Plast Reconstr Surg. 2006;118:Suppl.77S.
6. Elson ML. Injectable silicon for soft tissue augmentation. Cosmet Dermatol. 2005;18: 773-4.
7. Siqueira RC, Gil AD, Jorge R. Retinal detachment surgery silicon oil injection in transconjunctival sutureless 23-gauge vitrectomy. Arg Bras Oftalmol. 2007;70(6):905-9.
8. Prazeres J, Magalhaes Jr O, Lucatto LFA, Navarro RM, Moraes NS et al. Heavy silicon oil as a long-term endotamponade agent for complicated retinal detachments. BioMed Res Int. 2014; http://dx.doi.org/10.1155/2014/136031
9. Duan A, She H, Qi Y. Complications after heavy silicon oil tamponade in complicated retinal detachment. Retina. 2011;31:547-52.
10. Van Schie CH, Whalley A, Armstrong DG, Vileikyte L, Boulton AJ. Efficacy of injected liquid silicon in the diabetic foot to reduce risk factors for ulceration: A randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23:634-8.
11. Van Schie CH, Whalley A, Armstrong DG, Vileikyte L, Boulton AJ. The effect of silicon injections in the diabetic foot on peak plantar pressure and plantar tissue thickness: A 2-year follow-up. Arch Phys Med Rehabil. 2002;83:919-23.
12. Wallace WD, Balkin SW, Kaplan L, Nelson S. The histological host response to liquid silicon injections for prevention of pressure-related ulcers of the foot: A 38-year study. J Am Podiatric Med Assoc. 2004;94:550-7.
13. Gaber Y. Secondary lympoedema of the lower leg as an unusual side-effect of a liquid silicon injection in the hips and buttocks. Dermatology. 2004;208:342-4.
14. Merrill TJ, Mustafa ZC, Beverly M, Hernandez J. Silicon injection complications in the lower extremity: Migration, local reaction, and autoimmune response. http://www.podiatryinstitute.com/pdfs/Update_2010/2010_39.pdf
15. Ben-Hur N, Ballantyne DL Jr, Rees TD, Seidman I. Local and systemic effects of dimethylpolysiloxane fluid in mice. Plast Reconstr Surg. 1967;39:423-6.
16. Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging. 2007;11:99-110.
17. Liles DT, Lin F. Silicon Elastomeric Particles in Skin Care Applications. Science & Technology Department. 2010. Vol 1053. Chapter 11. P. 207-19.
18. Nair A, Jacob S, Al-Dhublab B, Attimarad M, Harsha S. Basic considerations in the dermatokinetics of topical formulations. Bras J Pharmaceut Sci. 2013;49:423-34.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Ago Harlim, Siti Aisah, Riwandi Sihombing
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
